Publication | Closed Access

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

MedicinePharmacologyFolinic AcidColorectal CancerPathologyVersus OxaliplatinCancer TreatmentOncologyRadiation OncologyMayo Clinic Regimen